In the same week that Servier announced its partnership with Paris, France-based Iktos, now Pierre Fabre Laboratories has ...

ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...

Cancer therapy and synthetic biology are converging around a shared problem that has long frustrated oncologists and ...

ProGro BIO today announced new third-party research demonstrating that Rhizol®, the company's flagship microbial soil ...

Understand the role of reproductive biotech in overcoming biological limits in fertility treatments and enhancing success ...

Is it possible to recover plastic recyclates from previously unused waste streams in order to produce high-quality fibers and ...

Seers Technology, D&D Pharmatech, OliX, ABL Bio. Among the top 10 stocks by share price growth this year, four were ...

aims to advance oncology research by integrating computational design, medicinal chemistry, biology, medical science and ...

Pierre Fabre Laboratories and Iktos, a global leader in Artificial Intelligence (AI) and Robotics on drug discovery, today ...

This important study introduces a new biology-informed strategy for deep learning models aiming to predict mutational effects in antibody sequences. It provides solid evidence that separating ...

Oppenheimer Research released a list of its best ideas for small-caps and mid-caps in the new year.

Data indicating unequal treatment effects in women has prompted calls for more nuance in Alzheimer’s diagnosis and drug ...